International safety notice
TYPE I INSULIN GROWTH FACTOR
Brazil / Anvisa · BRA · May 11, 2016
Key facts
| Title | TYPE I INSULIN GROWTH FACTOR |
|---|---|
| Regulator | Brazil / Anvisa |
| Country | BRA |
| Brand | Commercial name of the product: IGF-I - IMMULITE (Anvisa registration no.: 10345161109) /// Model(s) affected: Kit for 100 tests - Pearls 100u./ Reagent 1x7.5mL/ Adjusters mL (lyophilized) 2x4mL / Solution 1x30mL/// Affected batch: 411/// Product risk class: II. |
| Manufacturer | DETENTOR DO REGISTRO SIEMENS HEALTHCARE DIAGNÓSTICOS SA CNPJ 01449930000190 ENDEREÇO AV MUTINGA 3800 7º ANDAR PIRITUBA SP TEL 11 39083877 FABRICANTES SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD ENDEREÇO GLYN RHONWN LLANBERIS CAERNARFON GWYNEDD LL55 4EL |
| Models | 10345161109 |
| Date | May 11, 2016 |
| Regulator page | anvisa.gov.br |
At a glance
- No Recall
- No Field safety notice
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1